Risk of HPV-linked second cancers up after anal cancer

June 15, 2017

(HealthDay)—Survivors of squamous cell carcinoma of the anus (SCCA) have an elevated risk of human papillomavirus (HPV)-related second primary malignancies (SPMs), according to a study published online June 13 in Cancer.

Rebecca A. Nelson, Ph.D., and Lily L. Lai, M.D., from City of Hope in Duarte, Calif., used population-based data from 1992 through 2012 to identify patients with SCCA and examined their risk of HPV-related SPMs. To determine excess risk, they calculated standardized incidence ratios (SIRs) defined as observed to expected cases.

The researchers found that 416 of the 10,537 patients with SCCA developed HPV-related SPMs, which corresponded to an overall SIR of 21.5. Compared with women, men had higher SIR (35.8 versus 12.8). For a second SCCA, men had markedly higher SIRs than women (127.5 versus 47.0); for oral cavity and pharyngeal cancers, the SIRs were elevated in men and women (3.1 and 4.4, respectively). For sex-specific sites the SIRs were also elevated, with an SIR of 19.6 for male genital cancers and 8.3 for female genital cancers.

"Patients with index SCCA are at an increased risk of subsequent HPV-related SPMs," the authors write. "The elevated risk is most striking in patients with second primary SCCAs; however, the risk of second cancers also appears to be increased in other HPV-related sites."

Explore further: Increased cancer risk for childhood kidney recipients

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Increased cancer risk for childhood kidney recipients

April 5, 2017
(HealthDay)—Childhood kidney recipients have increased cancer risk, according to a study published online March 29 in the American Journal of Transplantation.

Study tracks patterns of US cases of anal canal carcinoma

April 2, 2013
(HealthDay)—Available screening and identification of human papillomavirus likely contributed to the increased incidences of squamous cell carcinoma of the anal canal (SCCA) and anal carcinoma in situ (CIS) after 1997, ...

Index CRC tumor site impacts increased CA risk for survivors

July 15, 2013
(HealthDay)—The location of index colorectal cancer (CRC) affects the incidence of second cancer after CRC, according to a study published online July 15 in Cancer.

Researchers uncover new potential biomarker and therapeutic target for aggressive breast cancer

April 29, 2011
(PhysOrg.com) -- In an analysis of more than 1,300 human breast tissue samples, a team of Stony Brook University School of Medicine researchers discovered a possible role of the squamous cell carcinoma antigen (SCCA) in the ...

Ovarian cancer rates declining in breast cancer survivors

January 8, 2013
(HealthDay)—Primary ovarian cancer incidence is declining in the United States, both among the general population and among breast cancer survivors, according to research published online Jan. 2 in the Journal of Clinical ...

Infection risk up before chronic immune thrombocytopenia

February 4, 2016
(HealthDay)—The incidence of primary chronic immune thrombocytopenia (cITP) is 2.30/100,000 person-years, and incidence is associated with increased risk of infections within the five years before cITP diagnosis, according ...

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.